Christopher Brett Primiano Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Christopher Brett Primiano is EVP, CBO, GC & Secretary of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 4,523 shares of KPTI, which is worth approximately $2,894. The most recent transaction as insider was on Dec 01, 2020, when has been sold 137,061 shares (Common Stock) at a price of $17.51 per share, resulting in proceeds of $2,399,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.52K

0% 3M change

0% 12M change

Total Value Held $2,894

Christopher Brett Primiano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2020	SELL Open market or private sale	$2,399,938 $17.51 p/Share	137,061 Reduced 96.81%	4,523 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$1,428,176 $10.42 p/Share	137,061 Added 68.35%	63,460 Common Stock
Nov 02 2020	SELL Open market or private sale	$11,518 $14.92 p/Share	772 Reduced 14.58%	4,523 Common Stock
Oct 13 2020	SELL Open market or private sale	$668,785 $17.03 p/Share	39,271 Reduced 89.41%	4,649 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$384,856 $9.8 p/Share	39,271 Added 87.97%	5,370 Common Stock

Also insider at

AURA

Aura Biosciences, Inc. Healthcare

Chief Business Officer

CBP